Graham Capital Management, L.P. Beam Therapeutics Inc. Transaction History
Graham Capital Management, L.P.
- $4.42 Billion
- Q3 2024
A detailed history of Graham Capital Management, L.P. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 10,410 shares of BEAM stock, worth $285,338. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,410
Previous 24,399
57.33%
Holding current value
$285,338
Previous $571,000
55.34%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
240Shares Held
76.3MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$225 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$215 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$209 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$194 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$133 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.93B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...